Eli Lilly to buy obesity drugmaker Versanis for nearly $2B

The Versanis acquisition marks yet another purchase for the dealmaking Lilly, which recently bought Sigilon Therapeutics for $34.6 million upfront and Dice Therapeutics for $2.4 billion.

Related Keywords

United States ,Americans ,Eli Lilly ,Mark Pruzanski ,Ruth Gimeno ,Sigilon Therapeutics ,Bay Area Based Dice Therapeutics ,